HeartCore Announces Preliminary Third Quarter 2024 Results
Q3 2024 Revenues Expected to Increase to Between $17 Million and $19 Million
Q3 2024 Net Income Expected to Increase to Between $9 Million and $11 Million
NEW YORK and TOKYO, Oct. 18, 2024 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or “the Company”), a leading enterprise software and data consulting services company based in Tokyo, announced select preliminary financial results for the third quarter ended September 30, 2024. These results are preliminary and unaudited, and are subject to all aspects of the final quarterly review process and may change as a result of new information that arises, or new determinations that are made, in this process.
Based on preliminary unaudited results, the Company expects revenues for the third quarter of 2024 to be between $17 million and $19 million, representing an increase of between 263% and 305%, compared to $4.7 million in the same quarter last year. Revenues for the nine months ended September 30, 2024 are expected to be between $26 million and $28 million, representing an increase of between 40% and 51%, compared to $18.5 million for the same period last year.
Net income is expected to be between $9 million and $11 million for the third quarter of 2024, compared to a net loss of $2.5 million in the same period last year. Net income for the nine months ended September 30, 2024 is expected to be between $5 million and $7 million, compared to a net loss of $1.8 million in the same period last year.
HeartCore’s “Software Related Business” and “Go IPO Business” include the following revenue streams:
Software Related Business
Revenues from on-premise software
Revenues from maintenance and support services
Revenues from software as a service (“SaaS”)
Revenues from software development and other miscellaneous services
Revenues from customized software development and services
Go IPO Business
“I am pleased to announce robust preliminary results for this past third quarter, the strongest quarter in HeartCore’s history,” said the Company CEO Sumitaka Kanno. “This significant increase is primarily due to the recent public listing of our Go IPO client, SBC Medical Group Holdings Incorporated (“SBC”). The Company is expected to report approximately $12 to $14 million in revenues from warrants issued by SBC for our IPO consulting services. This Go IPO deal is the biggest achievement since the business’ inception and underscores the immense value our consulting business presents. Additionally, we have an incremental three Go IPO deals that are slated to close over the next several months, and with an optimistic outlook on the U.S. IPO market for Japanese companies, we look forward to the completion of these deals that are set to further strengthen our financial results. We also shifted toward proposing multi-year software licensing agreements to our customers starting in 2024, and these agreements corresponded to increased revenues in our Software Related Business. 2024 is set to be the strongest year in HeartCore history, and we remain committed to retaining this upward trend for future quarters and years ahead. We look forward to providing the full details of our third quarter 2024 financial results in mid-November.”
Q3 2024 Net Income Expected to Increase to Between $9 Million and $11 Million
NEW YORK and TOKYO, Oct. 18, 2024 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or “the Company”), a leading enterprise software and data consulting services company based in Tokyo, announced select preliminary financial results for the third quarter ended September 30, 2024. These results are preliminary and unaudited, and are subject to all aspects of the final quarterly review process and may change as a result of new information that arises, or new determinations that are made, in this process.
Based on preliminary unaudited results, the Company expects revenues for the third quarter of 2024 to be between $17 million and $19 million, representing an increase of between 263% and 305%, compared to $4.7 million in the same quarter last year. Revenues for the nine months ended September 30, 2024 are expected to be between $26 million and $28 million, representing an increase of between 40% and 51%, compared to $18.5 million for the same period last year.
Net income is expected to be between $9 million and $11 million for the third quarter of 2024, compared to a net loss of $2.5 million in the same period last year. Net income for the nine months ended September 30, 2024 is expected to be between $5 million and $7 million, compared to a net loss of $1.8 million in the same period last year.
HeartCore’s “Software Related Business” and “Go IPO Business” include the following revenue streams:
Software Related Business
Revenues from on-premise software
Revenues from maintenance and support services
Revenues from software as a service (“SaaS”)
Revenues from software development and other miscellaneous services
Revenues from customized software development and services
Go IPO Business
“I am pleased to announce robust preliminary results for this past third quarter, the strongest quarter in HeartCore’s history,” said the Company CEO Sumitaka Kanno. “This significant increase is primarily due to the recent public listing of our Go IPO client, SBC Medical Group Holdings Incorporated (“SBC”). The Company is expected to report approximately $12 to $14 million in revenues from warrants issued by SBC for our IPO consulting services. This Go IPO deal is the biggest achievement since the business’ inception and underscores the immense value our consulting business presents. Additionally, we have an incremental three Go IPO deals that are slated to close over the next several months, and with an optimistic outlook on the U.S. IPO market for Japanese companies, we look forward to the completion of these deals that are set to further strengthen our financial results. We also shifted toward proposing multi-year software licensing agreements to our customers starting in 2024, and these agreements corresponded to increased revenues in our Software Related Business. 2024 is set to be the strongest year in HeartCore history, and we remain committed to retaining this upward trend for future quarters and years ahead. We look forward to providing the full details of our third quarter 2024 financial results in mid-November.”
Publicaciones relacionadas
Exención de responsabilidad
La información y las publicaciones que ofrecemos, no implican ni constituyen un asesoramiento financiero, ni de inversión, trading o cualquier otro tipo de consejo o recomendación emitida o respaldada por TradingView. Puede obtener información adicional en las Condiciones de uso.